Evli Likvidi vs UBS Lux Equity Fund Biotech USD

Evli Likvidi vs UBS Lux Equity Fund Biotech USD

1. Evli Likvidi

  • Security

    Evli Likvidi B

  • Fee

    0.31%

  • ISIN

    FI0008804463

  • Holdings

    11

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 12 holdings in Evli Likvidi, where the largest holding is Teollisuuden Voima (1.83), followed by Nordea (1.7) and Akelius (1.39). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in Evli Likvidi and UBS Lux Equity Fund Biotech USD.

Evli Likvidi UBS Lux Equity Fund Biotech USD
1. Teollisuuden Voima Oyj
Finland
1.83 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Nordea Bank Abp
Finland
1.7 %
2. Moderna Inc
9.21 %
3. Akelius Residential D
Sweden
1.39 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. SSAB B
Sweden
1.17 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Kojamo Oyj
Finland
1.17 %
5. AbbVie Inc
USA
4.91 %
6. Luminor Bank AS
Estonia
1.13 %
6. Gilead Sciences Inc
USA
4.66 %
7. Stora Enso Oyj R
Finland
1.12 %
7. Amgen Inc
USA
4.43 %
8. Fortum Oyj
Finland
1.06 %
8. BioNTech SE
4.13 %
9. Skanska B
Sweden
1.03 %
9. Karuna Therapeutics Inc
3.75 %
10. Akelius Residential Property Finance BV
1.03 %
-
11. Vestas Wind Systems A/S
Denmark
1.01 %
-

The list of fund holdings was last updated on July 25, 2025.